Cancer therapy cardiotoxicity detection: understanding the limitations of cardiac imaging

Affiliations

¹ Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA NLPalaskas@mdanderson.org.
² Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Editorial

Nicolas Palaskas et al. Heart. 2020 Jun.

. 2020 Jun;106(11):791-792.

doi: 10.1136/heartjnl-2020-316647. Epub 2020 Mar 16.

¹ Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA NLPalaskas@mdanderson.org.
² Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

No abstract available

Keywords: cardiac imaging and diagnostics; cardiac magnetic resonance (CMR) imaging; echocardiography.

Conflict of interest statement

Competing interests: None declared.

Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
Lambert J, Lamacie M, Thampinathan B, Altaha MA, Esmaeilzadeh M, Nolan M, Fresno CU, Somerset E, Amir E, Marwick TH, Wintersperger BJ, Thavendiranathan P. Lambert J, et al. Heart. 2020 Jun;106(11):817-823. doi: 10.1136/heartjnl-2019-316297. Epub 2020 Feb 25. Heart. 2020. PMID: 32098808